THE ROLE OF VITAMIN D IN THE PATHOGENESIS OF ADOLESCENT IDIOPATHIC SCOLIOSIS
 
   

The Role of Vitamin D in the Pathogenesis
of Adolescent Idiopathic Scoliosis

This section was compiled by Frank M. Painter, D.C.
Send all comments or additions to:
  Frankp@chiro.org
 
   

FROM:   Asian Spine J. 2018 (Oct 16) [Epub] ~ FULL TEXT

Shu-Yan Ng, Josette Bettany-Saltikov, Irene Yuen Kwan Cheung, Karen Kar Yin Chan

Institute of Health and Social Care,
Teesside University,
Middlesbrough, UK.


Several theories have been proposed to explain the etiology of adolescent idiopathic scoliosis (AIS) until present. However, limited data are available regarding the impact of vitamin D insufficiency or deficiency on scoliosis. Previous studies have shown that vitamin D deficiency and insufficiency are prevalent in adolescents, including AIS patients. A series of studies conducted in Hong Kong have shown that as many as 30% of these patients have osteopenia. The 25-hydroxyvitamin D3 level has been found to positively correlate with bone mineral density (BMD) in healthy adolescents and negatively with Cobb angle in AIS patients; therefore, vitamin D deficiency is believed to play a role in AIS pathogenesis. This study attempts to review the relevant literature on AIS etiology to examine the association of vitamin D and various current theories. Our review suggested that vitamin D deficiency is associated with several current etiological theories of AIS. We postulate that vitamin D deficiency and/or insufficiency affects AIS development by its effect on the regulation of fibrosis, postural control, and BMD. Subclinical deficiency of vitamin K2, a fat-soluble vitamin, is also prevalent in adolescents; therefore, it is possible that the high prevalence of vitamin D deficiency is related to decreased fat intake. Further studies are required to elucidate the possible role of vitamin D in the pathogenesis and clinical management of AIS.

KEYWORDS:   Bone density; Scoliosis; Vitamin D; Vitamin K



From the Full-Text Article:

Introduction

Table 1

Table 2

Table 3

Adolescent idiopathic scoliosis (AIS) affects 0.47%–11.1% of the general population. [1] As the name suggests, the cause of the condition remains unclear. Several theories have been proposed, including genetic, neuro-develop­mental abnormalities, motor control and motor-sensory integration dysfunctions, vestibular and proprioceptive disorders, biomechanical growth modulation, uncoupled spinal neuro-osseous growth, thoracospinal concept, sys­temic and metabolic disorders [2], and decreased bone density (Table 1). [3–5]

Recently, Schlösser et al. [6] in 2014 performed a struc­tured review of the literature regarding all the proposed and diverse etiologies proposed for the causes of AIS. They found that of all the theories, only those related to impaired gait control and decreased bone mineral density (BMD) had a moderate strength of evidence (Table 2). Other theories, including those of different volume of the cerebellar regions, asymmetric somatosensory evoked po­tentials, reduced trunk strength, decreased body weight, increased breast asymmetry, and impaired bone quality were only supported by weak evidence. [6]

Considering that vitamin D may reportedly play a role in the cerebral process of postural balance [7] and that serum vitamin D level is positively correlated with the BMD of the hip [8, 9] and negatively with the Cobb angle [10], vitamin D insufficiency or deficiency is speculated to influence AIS etiopathogenesis (Table 3).

In this study, we attempted to determine whether there is an association between vitamin D and the different cur­rent and relevant theories regarding AIS. We also assessed the impact of vitamin D deficiency or insufficiency on AIS development



Genetics and Vitamin D

It has long been known that hereditary factors play a role in the etiology of idiopathic scoliosis (IS). [11–13] In the previous 10–20 years, genetic association studies and genome-wide association studies (GWAS) have been used to identify single nucleotide polymorphism (SNP), namely, the variants of genes associated with AIS. [14] A genetic association study examines if one or more genes within a population co-occur with a disease more often than expected by chance occurrence, while GWAS involve the examination of the entire genome. [15]

While several GWAS have identified different SNPs as­sociated with AIS [16], they did not consider the specific mechanisms of how genes function within biological networks. [14] Pathway analysis has subsequently been developed to perform statistical tests on the lists of genes involved in the biological pathways for a significant rela­tionship with a particular phenotype or observable trait. [17]

Favaro [14] in 2017 reported the results of a pathway analysis of a list of genes affected in AIS. He found that the multiple pathways were significantly affected in AIS, including those of cancer; the endocrine system; the lung and heart stress response and repair; stem cell differentia­tion; as well as skeletal tissue growth, development, and repair.

It is noteworthy that vitamin D was involved in some pathways, including the spinal cord injury pathway, the lung fibrosis pathway, the endochondral ossification path­way, and the endocrine resistance pathway. [14]

  1. Spinal cord pathway and lung fibrosis pathway   Spinal cord injury and lung fibrosis pathways involve glial scar formation and focal adhesion in response to spinal cord injury. [18] Vitamin D and its analogs have been established to have an association with fibrosis regulation. Vitamin D has been used to treat fibrosis in multiple or­gans, including the lung, bone, and liver. [19–23] Early vi­tamin D supplementation significantly reduced the sever­ity of bleomycin-induced pulmonary fibrosis in mice. [21] In bones, a 3–9–month treatment course of calcifediol significantly decreased bone marrow fibrosis. [19] Simi­larly, sufficient vitamin D levels (> 50 nmol/L) decreased the occurrence of rapid fibrosis progression in chronic hepatitis patients. [20] It is possible that in a subset of AIS patients, tethering of the nerve roots may occur follow­ing spinal injuries. Fibrosis of the paravertebral muscles is observed after injury. [24] Moreover, compression of the sciatic nerve in rats induced fibrosis near the lesions and the ipsilateral dorsal root ganglion. This occurred 3 weeks after the compression using the Silastic tube. [25]

  2. Endochondral ossification pathway   Genetic pathway analysis also showed that genes related to the endochondral ossification pathway were over-repre­sented. [14] The pathway described genes involved in the replacement of the cartilaginous tissue by the bone tissue. Although the regulation of this process includes growth hormones, thyroid hormones, and transcription factors, among other molecules, vitamin D is also essential for the regulation of endochondral ossification. [26, 27]

  3. Endocrine resistance pathway   The endocrine resistance pathway describes the underly­ing biological mechanisms for resistance to the treatment of hormonal-responsive breast cancer. [14] Problems in regulating and responding to hormones could be the underlying cause of AIS. [14] Women with AIS are more likely than men to develop a spinal curve that progresses in severity. This indicates that a manifestation of the prob­lems in estrogen regulation may be an underlying cause of AIS, given that women tend to have higher estrogen levels than men. [28, 29]

    Several factors affect estrogen production, and vitamin D is a significant factor. Vitamin D deficiency report­edly reduces estrogen production. [30] This has been reported by Kinuta et al. [30] in 2000 who studied the role of vitamin D in the regulation of estrogen synthesis, using the vitamin D receptor (VDR) in null mutant mice. The authors reported that the mutant mice had gonadal insufficiencies that were normalized by estrogen supple­mentation and were partially normalized by calcium supplementation. [30] They concluded that vitamin D contributed to the regulation of estrogen synthesis [30] and that its deficiency reduced estrogen production. Fe­male rats with severe vitamin D deficiency had impaired fertility. [31] However, a study demonstrated that 4–week supplementation of vitamin D3 to women aged 18–22 years reduced the estradiol levels by 3%. [32] It is possible that the healthy volunteers had low normal vitamin D lev­els (55 nmol/L) at baseline [32] and saturating the VDR receptors with additional vitamin D3 did not increase es­trogen production.



Central Nervous System and Vitamin D

Abnormalities in the morphology and function of the central nervous system have long been implicated in the etiopathogenesis of AIS. Cervicothoracic syrinx [33, 34], low-lying cerebellar tonsils [35–37], and morphological abnormalities in the midbrain [38], pons medulla [39], and vestibular system [40] have all been reported in sub­groups of AIS subjects.

Functionally, AIS patients are reported to have a range of abnormalities in postural balance, propriocep­tive disturbance [41, 42], oculo-vestibular function [43], vestibular-evoked postural response [44], somatosensory functions [45–47], and motor control. [48] Beaulieu et al. [47] in 2009 and Haumont et al. [49] in 2011 both showed that postural balance dysfunction is related positively to the severity of curvatures. AIS patients with greater cur­vatures and poorer balance control use fewer anticipatory strategies to stabilize body oscillations. [49]

  1. Central nervous system morphological changes and vitamin D   The morphologic changes observed in the brain of AIS subjects may be related to vitamin D deficiency or insuffi­ciency. Growing evidence is showing that vitamin D is in­volved in brain development in rats and mice [50–52] be­cause VDRs are expressed widely in the temporal, orbital, and cingulate cortices; in the thalamus; midbrain-pontine central grey and spinal cord in rats and mice. [50, 53–55] Hawes et al. [51] in 2015 determined the influence of vita­min D deficiency during pregnancy on brain development in mice. Female albino house mice that did not have vita­min D3 receptors were placed on either a vitamin D (con­trol) or a vitamin D-deficient diet for 5 weeks prior to and during pregnancy. [51] Fetal brains were then examined morphologically, and gene expression was analyzed. Vita­min D deficiency during pregnancy reduced fetal crown–rump length and head size. [51] Other similar studies showed that the offspring of vitamin D3-deficient rats were heavier than the control animals, although there was no difference in the ratio of brain to body weight between the groups. [50] They had larger lateral ventricles [56, 57], double the size of those in controls even when corrected for the increased hemispheric volume. [50] The mice also had a thinner cortex. [56] Similarly, Caucasian elderlies deficient in 25-hydroxyvitamin D (25[OH]D) (<50 nmol/L) had larger ventricles than those of subjects with normal 25(OD)D levels (>50 nmol/L). [58] Vitamin D depletion is reportedly associated with lower brain volume [59].
    Figure 1

    In addition, McGrath et al. [50] in 2004 and Eyles et al. [60] in 2005 have shown that the VDR is also expressed in the human brain. They reported the presence of 1α-hydroxylase, the enzyme responsible for the forma­tion of the active vitamin D in the human brain. [60] The distribution of VDR in the human brain is similar to that reported in rodents. [60] VDR is found in the hippocam­pus; cortex; limbic systems; and the olfactory, visual, and auditory systems in the human brains (Figure 1). [50, 61, 62] This may suggest that vitamin D can modulate brain func­tion in health and disease. [52]

    Further, Kuether and Piatt [63] in 1998 described a case of marked vitamin D deficiency. The patient presented with vitamin D-resistant rickets that involved the base of the cranium and precipitated the development of Chiari malformation and associated syringomyelia [63], features observed in some AIS patients. It is possible that vitamin D3 deficiency in some AIS patients causes similar subclin­ical changes. Further, Zhang et al. [64] in 2016reported spinal cord abnormalities in 18.7% of the ‘presumed’ in­fantile and juvenile IS patients. Of these, 65% had Arnold-Chiari malformation with or without syringomyelia.

  2. Postural balance, motor performance, and vitamin D   Vitamin D deficiency causes poorer balance or posture control in mice and humans. [7, 65–67] Kalueff et al. [68] in 2004 have shown that mice with VDR ablation had impaired motor performance. Therefore, it is possible that VDR deficiency affects the modulation of brain neu­rotransmitters, such as acetylcholine and catecholamines, and disrupts the vitamin D-VDR signaling pathways, re­sulting in impaired motor performance. [68]

    Minasyan et al. [65] in 2009 also examined the balance functions in VDR deficient mice. They found that the VDR deficiency in mice was associated with decreased balance functions. These findings may be relevant to poorer balance and posture control in humans with low vitamin D levels. [65] Beauchet et al. [66] in 2011 studied the association between the stride-to-stride variability of stride time (STV) and serum 25(OH)D levels in adults >65 years old. Results showed that subjects with serum 25(OH)D <10 ng/mL representing severe vitamin D de­ficiency had a low lower limb proprioception score and a high STV (worse performance). [66] A similar study by Krause et al. [67] in 2014 evaluated the impact of vitamin D level on postural body sway (PBS) in 342 elderly sub­jects. They evaluated the different PBS parameters on a force plate with feet in close stance or hip-width stance with eyes open or closed. [67] Patients with significant vi­tamin D deficiency (<10 µg/mL) had significantly higher PBS and hip-width stance than those with normal serum vitamin D levels (>30 µg/L). [67] In another study, pa­tients who were >60 years old and whose serum 25(OH)D levels were <50 nmol/L had a lower stability index than those with normal serum 25(OH)D. [7] Patients with se­rum 25(OH)D level >50 nmol/L had significantly better standing balance, gait, and chair stand performance com­pared to those with serum 25(OH)D <50 nmol/L. [7]

    Patients with vitamin D3 deficiency who were supple­mented with vitamin D3 showed improved postural bal­ance. [69–71] Anek et al. [69] in 2015 examined the effect of short-term supplementation of vitamin D3 on the balance ability of 52 women aged 45–55 years old. They found that the balance ability of 26women supplemented with 20,000 IU/wk vitamin D2 for 4 consecutive weeks was significantly improved compared with that at baseline and compared with that of the control group who had not received any supplementation. Similar findings were re­ported by Cangussu et al. [70] in 2016 in younger (50–65 years) postmenopausal subjects with vitamin D deficiency. They supplemented one group with 1,000 IU/day vitamin D3 orally; the other group received no supplementation. After 9 months, the 25(OH)D level of the supplemented group increased; no such increase was observed in the control group. [70] The balance of the supplemented group improved, and they exhibited a reduction in body sway, as measured with stabilometry. In contrast, there was no im­provement in the balance of the control group. [70]

Thus, it is clear that vitamin D may play a role in the cerebral process of postural balance. [7] However, the un­derlying mechanism remains unknown. Sanyelbhaa and Sanyelbhaa [82] in 2015 reported a high prevalence of ab­normal ocular vestibular-evoked myogenic potentials and cervical vestibular-evoked myogenic potentials in patients with vitamin D deficiency, suggesting possible otolith dys­function that affected both the utricle and saccule. Thus, it is possible that vitamin D deficiency may affect postural balance through disturbance of the vestibular system, which has been found to be dysfunctional in AIS patients. [44]



Skeletal Growth, Menarche, and Vitamin D Status

Several studies have reported that the skeletal growth pat­tern in AIS subjects is disturbed. [73–77] This has been at­tributed to the age of onset of menarche [76, 77], reduced serum vitamin D level, and/or polymorphism or varia­tions in the VDRs. [78]

AIS subjects are reportedly taller than healthy controls. [73–77] However, after the age of 13 years, the height difference between AIS and control subjects disappeared. [77, 79] With respect to the sexual maturity, Siu King Cheung et al. [80] in 2003 reported that girls with AIS were shorter before menarche; however, they grew taller and had a longer arm span during the growth spurt com­pared to healthy controls. Studies have shown that there are insignificant differences in the height between patients and controls at the end of the growth period, and the growth pattern of AIS patients has thus far been regarded as essentially normal. [76, 77] In fact, in a recent review, Schlösser et al. in 2014 stated that there was only weak evidence in support of corrected body height changes as an etiological factor of AIS. [6]

These different findings may be related to the age of onset of menarche reported in different studies. [76, 77, 80] Ylikoski [76] in 2003 and Goldberg et al. [77] in 1993 reported that AIS girls experience earlier menarche with an earlier growth spurt. Other authors have reported contradictory findings. [81–84] Warren et al. [81] in 1986 reported a higher prevalence of scoliosis in ballet danc­ers, all of whom had delayed menarche. Mao et al. [82] in 2011 found that the average age of onset for menarche in Chinese girls with AIS girls was significantly later than in normal controls. Yim et al. [83] in 2012 also reported that Chinese AIS girls had an average delay of 0.49 years in the age of onset of menarche compared to healthy controls.

Table 4

Many factors influence the age of onset of menarche. These include genetics, estrogen level, vitamin D status, polymorphism of VDR, and latitude [78, 85] (Table 4). Twin studies have shown that as much as 68% of the vari­ance in age at menarche may be genetically determined. [85] A decrease in the estrogen level is related to a delay in menarche. [82] Likewise, vitamin D deficiency and VDR polymorphism affect the timing of menarche. [78, 85] Villamor et al. [86] in 2011 showed that vitamin D3 defi­ciency is associated with an early onset of menarche by as much as 9 months. Latitude reportedly affects the time of onset of menarche, possibly through its influence on mel­atonin secretion and vitamin D synthesis. [87–89] Girls who live at higher latitudes appear to experience men­arche later than girls who live closer to the equator. [87–89] Grivas et al. [87] in 2006attributed the differences in the age of onset of menarche in different latitudes to the pos­sible differences in melatonin secretion. [87] However, it is also possible that the differences in menarche onset are related to the serum vitamin D level. At higher latitudes where the ultraviolet radiation is less intense, the cutane­ous synthesis of vitamin D is decreased. [88, 90] This may also be related to the delay in menarche onset. Dossus et al. [88] in 2013 showed that on a continuous scale, an increase of 1° latitude was associated with 0.04 years older age of onset of menarche, whiles a 1–kJ/m2 increase in the annual ultraviolet radiation dose resulted in a 0.42 years younger age at menarche. Hagenau et al. [90] in 2009 showed that there was a 25(OH)D level decrease with latitude in European Caucasians; however, this was not observed in non-Caucasians. Studies have shown that an increase in the serum vitamin D level is associated with earlier menarche onset and vice versa. [88, 90]

Overall, the results are controversial. Studies have shown that both low and increased serum vitamin D level are associated with an earlier age of onset of menarche. [86, 88] The contradictory findings may be attributable to the confounding effects of childhood obesity and higher leptin levels. [91] In obese girls, more serum 25(OD)D is bound to the adipose tissues. Moreover, the higher amount of adipose tissues increases the tissue dilution of the vitamin, resulting in lower serum 25(OH)D levels, in­fluencing the outcome.

Furthermore, the mechanism underlying the associa­tion of vitamin D with the timing of menarche has not been clearly elucidated. It is possible that vitamin D acts through estrogen to affect the timing of menarche. The deficiency of vitamin D may reduce estrogen synthesis [30] and the expression and activity of several enzymes related to the production of sex steroids. [92] In addition, the in­teractions between the signaling pathways of estrogen and 1,25-vitamin D3 have also been identified. [93]



Osteopenia and Vitamin D

Osteopenia is a condition characterized a lower than normal BMD. In particular, it is defined as BMD with a T-score between –1.0 and –2.5. T-score is the number of standard deviations above or below the mean value for a healthy 30–year-old adult of the same sex and ethnicity as the patient. Recent studies have shown that 29.5% [94] to 38% of AIS patients have osteopenia . [3, 95, 96] Burner et al. [97] in 1982 were the first to report relative osteoporo­sis in children with IS. Similarly, Velis et al. [98] in 1988 used the Singh femoral trabecular index, a classification system for the bone density of the femoral neck based on the visibility of the trabecular types that can be seen in the femoral neck to show that scoliosis patients presented with early trabecular bone loss in the hips. Thereafter, osteopenia in AIS patients has been confirmed in many studies [95, 99–101] using dual photon-absorptiometry and dual energy X-ray absorptiometry. Osteopenia has been found not only in the spine [3, 99], but also in the radius [102], hips [99–101], and tibia; therefore, the de­crease in bone density is a generalized rather than a local phenomenon.

Follow-up studies have also shown that the bone quality in AIS patients is also affected. [100, 102] Tam et al. [102] in 2014 found that the cortical density of the radius of the non-dominant hand of AIS patients was significantly reduced as compared to that in healthy controls. The tra­becular density, trabecular number, and thickness also reportedly decreased [102], making the patients prone to fracture.

Further, the presence of a generalized reduction in BMD prompted Cheng et al. [3] in 1999 to suggest that osteopenia may have an etiopathogenetic role in AIS. Lee et al. [4] in 2005 demonstrated that BMD was inversely related to curve severity in 919 girls with AIS during the peri-pubertal period. AIS patients with lower BMD gen­erally had a higher Cobb angle, while those with normal BMD had smaller curves. [4] This concurred with the findings of Wang et al. [101] in 2017 In fact, Hung et al. [5] in 2005 who followed up a cohort of 324 girls with AIS until skeletal maturity or progression of curves ≥6° found that osteopenia was a significant prognostic factor for curve progression.

Lee et al. [4] in 2005 compared the calcium intake and time spent in physical activities in 596girls with AIS girls and 302 age-matched healthy controls. They found that the median calcium intake of AIS patients did not dif­fer significantly from that of healthy controls. However, the median time spent by the former (AIS patients) in physical activities was slightly less than that spent by the controls. [5] Other studies have shown that osteopenia observed in AIS patients is related to vitamin D insuf­ficiency and deficiency. [10, 103, 104]Longitudinal and cross-sectional studies have also demonstrated that the 25(OH)D level positively correlated with BMD in healthy children and adolescent. [105–108] The serum 25(OH)D level of pre-pubertal children at ages 7.6, 9.9, and 11.8 positively correlated with cortical bone mineral content (BMC), cortical thickness, and predicted bone strength at the age of 15.5 years. [108] Pubertal girls with lower vitamin D levels were at risk of not reaching the maximum peak bone mass, particularly at the lumbar spine. [105] Moreover, Balioglu et al. [10] recently demonstrated a negative correlation between serum vitamin D levels and the Cobb angle. Thus, these results further suggest that vitamin D may play an etiopathologic role in AIS develop­ment.

The age of onset of menarche is a determinant factor of peak BMD in young girls. Fox et al. [109] in 1993 and Tuppurainen et al. [110] in 1995 reported that BMD is related to the age of onset of menarche. Early menarche is associated with higher circulating estrogen levels dur­ing and after menarche [111, 112] and a high peak bone mass. [113] Late menarche is associated with a low BMD. [109, 110, 113] A Chinese cohort study found patients aged <40 years who had experienced late menarche (at age >14 years) had an approximately two-fold higher risk of low areal BMD at the hips. [114] Similarly, a Korea Na­tional Health and Nutrition Examination Survey (2008–2011) showed late menarche is associated with a lower BMD in the lumbar spine. [114] The age at menarche is correlated not only with BMD, but also with bone micro­structure. [115] Young healthy girls with a higher age of onset of menarche displayed lower total volumetric BMD, cortical volumetric BMD, and cortical thickness at the forearm than those with a lower age of onset of menarche. [115]



Hormones and Vitamin D

Many hormones and metabolites have been implicated in the etiopathogenesis of IS. Among these, estrogen, melatonin, and leptin are important. [116–121] Platelet calmodulin and osteopontin were possibly of second­ary importance in AIS pathogenesis. It is possible that all these hormones and proteins interact to influence BMD and vertebral bone quality, thereby affecting AIS develop­ment.

  1. Estrogen and vitamin D   AIS prevalence is higher in girls than in boys, particularly when the Cobb angle is >30°. [122] Further, the associa­tion of greater curvatures with delayed menarche has raised the interest regarding estrogens in the scoliosis communities because estrogens may play a role in the etiopathogenesis of IS. [29] The estrogen level in AIS sub­jects has been extensively studied. Raczkowski [123] in 2007 found no difference in the estradiol level of 27 girls with AIS and age-matched controls. The findings were supported by Sanders et al. [124] in 2007. In contrast, Ku­lis et al. [116] in 2006found that the estradiol level of girls with AIS was lower than that of the age-matched controls. This was in agreement with the report of Esposito et al. [117] in 2009. In addition, Kulis et al. [125] in 2015 found that the reduction in estradiol level occurred both pre- and post-menarche onset in AIS patients as compared to that in healthy controls. The reduction was more signifi­cant before than after menarche onset. [125]

    Estrogen has multiple functions. In addition to its re­productive functions, it regulates skeletal growth and development, promotes bone absorption, is involved in matrix metabolism, and maintains normal bone den­sity. [29] It is also involved in the normal closure of the growth plates in both sexes. [126] Thus, reduced estrogen production delays the development of bone maturity. [126] In fact, hypoestrogenism is associated with a higher prevalence of AIS. [81]

    Figure 2

    Figure 3

    Estrogen does not act alone, it interacts with melato­nin and vitamin D. This interaction is achieved by the modulation of the activity of melatonin; 17-β-estradiol, an estrogen, affects the functions of melatonin [127] and inhibits its melatonin. [128] The signaling pathways of estrogen and melatonin interact (Figure 2). [127, 129] In ad­dition, estrogen interacts with vitamin D (Figure 3). Further, estrogen stimulates renal 1α-hydroxylase activity, convert­ing 25(OH)D to 1,25-dihydroxyvitamin D, a biologically more active form of vitamin D. [130] 17-β-estradiol also upregulates the expression of the VDR gene [131] and in­creases intestinal calcium absorption through vitamin D-dependent mechanisms. Vitamin D is also involved in the regulation of estrogen synthesis. [30] Moreover, 1,25(OH)2 vitamin D3 upregulates the estrogen-binding proteins. [132] Further, the estrogen and VDR genotypes interact and influence the age of menarche [133] and BMD. [134]

  2. Melatonin and vitamin D   Melatonin, also known as N-acetyl-5-methoxy trypt­amine, is a hormone produced by the pineal gland in ani­mals; it regulates sleep and wakefulness. Melatonin defi­ciency has been implicated in AIS pathogenesis. [135, 136] However, subsequent studies did not agree with the theory that melatonin deficiency is a primary cause of AIS. [137–139] More recent trials, however, show that patients with severe AIS have dysfunctional melatonin signaling. [118, 119, 140]

    In AIS patients, melatonin possibly exerts its effects through its influence on bone growth and development. Melatonin induces the proliferation and stimulation of type I collagen synthesis in primary human osteoblasts [141, 142] and enhances osteoid mineralization and os­teoblast differentiation in mice and rat cell cultures. [143] Reduce melatonin secretion may contribute to the devel­opment of osteoporosis in humans. [129] Epidemiological studies on a study sample comprising more than 38,000 postmenopausal women who worked night shifts for ≥20 years demonstrated significantly increased risks of wrist and hip fractures over an 8–year follow-up period in these women as compared to those in women who had never worked night shifts. [144] Night shift work disturbs the patterns of melatonin secretion with severe circadian rhythm disruption. [145]

    It is noteworthy that vitamin D and melatonin report­edly interact with each other. In multiple sclerosis patients treated with interferon β (IFN-β), natural cell-signaling proteins produced by the body that have antiviral, immu­nomodulatory, and antiproliferative properties, melatonin secretion was negatively correlated with alterations in the serum 25(OH)D levels. [146] In a randomized control study, 3–month supplementation with a high dose of vita­min D to 40 IFN-β treated multiple sclerosis patients sig­nificantly decreased the overnight secretion of melatonin. [146] The reduction in the serum 25(OH)D levels was accompanied by an increase in the nighttime secretion of melatonin. [146]

    It is possible that 25-hydroxyvitamin D is a mediator in melatonin production. [146] Melanin production from the pineal gland is stimulated by darkness and inhibited by light. Photic stimulation from the retina is transmitted to the pineal gland via the suprachiasmatic nucleus of the hypothalamus. [147] VDR is strongly expressed in the supraoptic nucleus of the hypothalamus; therefore, Golan et al (2013) speculated that 25(OH)D acted as mediator, transmitting the ‘message of light’ to the pineal glands, leading to decreased melatonin synthesis (Fig. 1). [146]

  3. Leptin and vitamin D   Leptin is an adipocyte-derived hormone; once synthe­sized, it is released into the blood stream to stimulate the brain for the regulation of appetite and energy consump­tion. In obese subjects with a large fat mass, leptin secre­tion is increased. In contrast, it is reduced in lean indi­viduals.

    Leptin primarily suppresses appetite and maintains the energy homeostasis. It also affects bone metabolism [148] and the production of gonadal hormones by its effects on the hypothalamus. [149] Several girls with AIS girls have low leptin levels with other risk factors associated with AIS, including a low body mass index (BMI), reduced bone mass, and delayed puberty [80, 150, 151]; thus, low leptin levels are believe to be a cause of AIS. [120, 121]

    Leptin primarily influences bone metabolism via two different pathways, the central and peripheral pathways that favor the breakdown and formation of the bones, respectively. In mice, the intracerebroventricular infusion of leptin stimulates hypothalamic leptin receptor expres­sion and the sympathetic nervous system, enhancing bone resorption. [151, 152] However, peripherally, leptin promotes the differentiation of bone marrow stromal cells into osteoblasts and decreases the breakdown of bones, thus encouraging bone formation. [153, 154] Thus, skeletal bone mass depends on the interplay of these two mecha­nisms. [153] Low leptin levels are reportedly associated with abnormal bone microarchitecture. [149]

    Leptin may also possibly influence AIS pathogenesis via its effects on puberty, although the results are contro­versial. Leptin plays a significant role in the maintenance of the hypothalamic-gonadal-pituitary axis; it acts on the hypothalamus, pituitary gland, and gonadal glands as if they form a single entity acting collaboratively. Matkovic et al. [166] in 1997 demonstrated that leptin levels were inversely correlated with age of onset of menarche in girls with and without AIS. Low leptin levels are associated with delayed puberty. [149, 150] The replacement of leptin in deficient individuals restored puberty and fertility. [156]

    Burwell et al. [121] in 2016 ecently postulated that a reduction in the serum leptin levels plays a role in the cascade of AIS pathogenesis. Clinical studies have shown that serum leptin concentration is proportional to the to­tal body weight, fat mass, [148] and vitamin D level.[157] Elevated serum leptin levels are observed in obese indi­viduals, while reduced levels are seen in those with a low body weight. [148] Clark et al. [120] in 2014 investigated the relationship of BMI at the age of 10 years and the presence of scoliosis at the age of 15 years. They found a negative association between the BMI/body weight at the age of 10 years and scoliosis at the age of 15 years, with a 20% reduced risk of scoliosis per one standard deviation increase in the BMI. This suggested that girls with a lower BMI are at a higher risk of scoliosis. [120]

    Leptin levels are also associated with serum vitamin D levels. Menendez et al. [158] in 2001 and Kim et al. [159] in 2013 have shown an inverse relationship between leptin levels and 25(OH)D levels. A reduction in the 25(OH)D level is associated with an increase in the leptin level and vice versa. In obese subjects, leptin is secreted by the adi­pose tissue to induce satiety. In the presence of abundant adipose tissue, more vitamin D is absorbed into the tissue, reducing the circulating vitamin D level. In contrast, in lean individuals who have less adipose tissue, less leptin is secreted. Moreover, less vitamin D is absorbed into the adipose tissue. This increases the circulating vitamin D levels. [158] Thus, it is clear that 25(OH)D negatively and powerfully controls leptin secretion by the human adipose tissue. [158]



The Role of Vitamin D in the Etiopathogenesis of Adolescent Idiopathic Scoliosis

Table 5

Currently, AIS is considered a multifactorial heteroge­neous disease [160], with genetic and environmental fac­tors influencing its etiopathogenesis. [161, 162] Vitamin D deficiency and osteopenia were prevalent among AIS patients [10] and were positively correlated with the Cobb angle. Therefore, we speculated that vitamin D deficiency may play a role in AIS development, possibly by influenc­ing fibrosis regulation [163], postural control, and regula­tion of bone metabolism [10] (Table 5).

In children with vitamin D deficiency, spinal cord or spinal column injury in children may be repaired by fi­brosis, setting the background for the tethering of the nerve roots. Abe et al. [24] in 2017 injured the right side of the paravertebral muscles of 30, 8–week-old male rats. Thereafter, they performed histological examination and comparison of the muscle fibers and dorsal root ganglia on both the sides 1–3 weeks post-intervention. They found the cicatrix formed after the injury may sensitize the dominant nerve in the dorsal root ganglia. [24] Li et al. [25] in 2016 studied the effects of compression of the sciatic nerve in rats to investigate the pathological altera­tions in the neurons of the dorsal root ganglia. [25] They reported at 3 weeks after the compression, collagen fibers accumulated around the compressed sciatic nerve, and at 8 weeks, excessive collagen formation with muscle atrophy was observed. [25] The volume of collagen gradually and significantly increased following sciatic nerve compres­sion.

The amount of collagen I fibers surrounding the ip­silateral dorsal root ganglion was higher than that on the contralateral side [25], suggesting that injuries to the para­vertebral muscles and nerve roots are healed with fibrosis. It is possible that in a subset of AIS patients with vitamin D deficiency, spinal injury in childhood is healed by fi­brosis, with resultant nerve root tethering. As per clinical reports, fibrosis and scar tissue formation after surgery in childhood may be associated with AIS. [164, 165] Lebel and Lebel [164] in 2016reported a case of a female pa­tient with AIS who underwent surgical excision of a 4–cm benign ganglioblastoma from the left posterior rib cage at the age of 3 years. Post-surgical radiographs at the age of 8 years showed fusion of left 4th and 5th ribs. The patient was diagnosed with AIS at 11 years of age [164]. Similarly, Brooks et al. [165] in 2009 reported a case of AIS, possibly secondary to right inguinal herniorrhaphy performed before 6.25 years of age. By the age of 6.5 years, an asym­metric posture was apparent in a casual photograph, and after puberty, a marked deformity was evident. [165]

Artaza and Norris [163] in 2009 exposed mesenchymal multipotent cells to the active form of vitamin D. They found that vitamin D decreased the expression of trans­forming growth factor β 1 and the plasminogen activator inhibitor, both of which are profibrotic factors, leading to reduced collagen deposition.

Vitamin D deficiency is also found to reduce postural control; supplementation of vitamin D improves the pos­tural control in elderly individuals with vitamin D defi­ciency. [69–71] Whether this has any implications in AIS subjects warrants further investigation.

Insufficiency and deficiency of vitamin D may also play a role in AIS pathogenesis through its effects on bone metabolism. Vitamin D possibly interacts with estrogen, melatonin, and leptin to affect the BMD and BMC of the bones, including the vertebrae. [3, 9, 10, 30, 131, 146, 158] Recently, vitamin K2 was also found to be important for regulating bone metabolism. Vitamin K2 facilitates the deposition of calcium in the bones by the carboxyl­ation of osteocalcin, the synthesis of which is induced by 1,25-(OH)2D3. [166] Vitamin D deficiency reduces the carboxylation of osteocalcin and reduces the BMC of the total body and the lumbar spine. [167] It is noteworthy that many peri-pubertal healthy adolescents have subclin­ical deficiency of vitamin D [105, 168–170] and vitamin K2. [167, 171, 172] This may be attributable to the high bone turnover in children [105, 172] and the fat-restricted diet that is commonly enforced by the parents, given the fact that both vitamin D and K2 are fat-soluble vitamins. Defi­ciency of vitamin D, vitamin K2, estrogen, melatonin, and leptin levels is associated with a reduction in the BMD. [8, 9, 129, 150, 173] It is possible that the resultant osteope­nia from the deficiencies make the vertebrae susceptible to wedge deformity in the early stages of AIS [174–181], contributing to the initiation and/or progression of the curvature.

Recent studies have shown that asymmetric loading of the osteopenic vertebrae may cause vertebral wedg­ing through creeping, a continuous deformation under constant load. [182, 183] Lowered vertebral BMD is as­sociated with a higher Cobb angle and increased risk for curve progression. [4, 5, 184] Studies have shown that sustained compressive loading can cause progressive and measurable creep deformity in osteopenic elderly human vertebrae [182, 183], with a mean BMD <0.15 g/cm3 that results in vertebral wedging. [182] Wren et al. [185] in 2017 reported that lateral thoracic vertebral body wedging is negatively correlated with the vertebral cross-sectional area (CSA) in girls with AIS. Thus, vertebral body wedg­ing is more likely to occur in the thoracic spine that has a small vertebral CSA, particularly in the presence of osteo­penia. [186] In skeletally immature patients, continuous asymmetric growth on the concave and convex sides of a scoliosis curve would increase vertebral wedging, further contributing to an increase in the curvature. [185, 187]



Conclusions

Our literature review demonstrated an association be­tween vitamin D status and BMD, menarche, and other hormones. Although lower vitamin D levels are correlated with the Cobb angle, the relationship between vitamin D and AIS may not be casual. Further studies are required to determine whether vitamin D definitely plays a casual role in the etiopathogenesis of AIS and whether vitamin D deficiency is related to the tethering of the nerve roots and postural control dysfunctions observed in some AIS subjects. Longitudinal studies may also be required to ex­amine the effects of fat-restricted diets as well as vitamin D and K2 supplementation on the progression and man­agement of the scoliosis curves.

Further, it may be interesting to determine if the wide­spread deficiencies of vitamin D and K2 in adolescents are related to the increased need for vitamin D and K2 during pubertal growth and/or to the adherence to the now chal­lenged fat- and cholesterol-restricted diets [188] that have been promoted since the early 1980s to reduce the risk of cardiovascular diseases.


Conflict of Interest

No potential conflict of interest relevant to this article was reported.



References:

  1. Konieczny MR, Senyurt H, Krauspe R. Epidemiol­ogy of adolescent idiopathic scoliosis. J Child Orthop 2013;7:3-9.

  2. Burwell RG, Dangerfield PH, Freeman BJ. Con­cepts on the pathogenesis of adolescent idiopathic scoliosis: bone growth and mass, vertebral column, spinal cord, brain, skull, extra-spinal left-right skel­etal length asymmetries, disproportions and mo­lecular pathogenesis. Stud Health Technol Inform 2008;135:3-52.

  3. Cheng JC, Guo X, Sher AH. Persistent osteopenia in adolescent idiopathic scoliosis: a longitudinal follow up study. Spine (Phila Pa 1976) 1999;24:1218-22.

  4. Lee WT, Cheung CS, Tse YK, et al. Association of osteopenia with curve severity in adolescent idio­pathic scoliosis: a study of 919 girls. Osteoporos Int 2005;16:1924-32.

  5. Hung VW, Qin L, Cheung CS, et al. Osteopenia: a new prognostic factor of curve progression in ado­lescent idiopathic scoliosis. J Bone Joint Surg Am 2005;87:2709-16.

  6. Schlosser TP, van der Heijden GJ, Versteeg AL, Castelein RM. How ‘idiopathic’ is adolescent idio­pathic scoliosis?: a systematic review on associated abnormalities. PLoS One 2014;9:e97461.

  7. Akdeniz S, Hepguler S, Ozturk C, Atamaz FC. The relation between vitamin D and postural balance ac­cording to clinical tests and tetrax posturography. J Phys Ther Sci 2016;28:1272-7.

  8. Viapiana O, Gatti D, Rossini M, Idolazzi L, Fracassi E, Adami S. Vitamin D and fractures: a systematic review. Reumatismo 2007;59:15-9.

  9. Gatti D, El Ghoch M, Viapiana O, et al. Strong rela­tionship between vitamin D status and bone mineral density in anorexia nervosa. Bone 2015;78:212-5.

  10. Balioglu MB, Aydin C, Kargin D, et al. Vitamin-D measurement in patients with adolescent idiopathic scoliosis. J Pediatr Orthop B 2017;26:48-52.

  11. Wynne-Davies R. Familial (idiopathic) scoliosis: a family survey. J Bone Joint Surg Br 1968;50:24-30.

  12. Riseborough EJ, Wynne-Davies R. A genetic survey of idiopathic scoliosis in Boston, Massachusetts. J Bone Joint Surg Am 1973;55:974-82.

  13. Tang NL, Yeung HY, Hung VW, et al. Genetic epide­miology and heritability of AIS: a study of 415 Chi­nese female patients. J Orthop Res 2012;30:1464-9.

  14. Favaro D. Genetic pathway analysis of adolescent id­iopathic scoliosis [bachelor’s thesis]. Meadville (PA): Allegheny College; 2017.

  15. Wang K, Li M, Hakonarson H. Analysing biological pathways in genome-wide association studies. Nat Rev Genet 2010;11:843-54.

  16. Manolio TA. Bringing genome-wide association find­ings into clinical use. Nat Rev Genet 2013;14:549-58.

  17. Moore TJ, Furberg CD. The safety risks of innova­tion: the FDA’s Expedited Drug Development Path­way. JAMA 2012;308:869-70.

  18. Kutmon M, Rieswijk L. Spinal cord injury (bos tau­rus) [Internet]. San Francisco (CA): WikiPathways; 2016[cited 2017 Sep 30]. Available from: http://www.wikipathways.org/index.php/Pathway:WP3186.

  19. Teitelbaum SL, Bone JM, Stein PM, et al. Calcifediol in chronic renal insufficiency: skeletal response. JAMA 1976;235:164-7.

  20. Barchetta I. Could vitamin d supplementation ben­efit patients with chronic liver disease? Gastroenterol Hepatol (N Y) 2012;8:755-7.

  21. Zhang Z, Yu X, Fang X, et al. Preventive effects of vitamin D treatment on bleomycin-induced pulmo­nary fibrosis. Sci Rep 2015;5:17638.

  22. Ramirez AM, Wongtrakool C, Welch T, Steinmeyer A, Zugel U, Roman J. Vitamin D inhibition of pro-fibrotic effects of transforming growth factor beta1 in lung fibroblasts and epithelial cells. J Steroid Biochem Mol Biol 2010;118:142-50.

  23. Zhang GY, Cheng T, Luan Q, et al. Vitamin D: a novel therapeutic approach for keloid, an in vitro analysis. Br J Dermatol 2011;164:729-37.

  24. Abe K, Inage K, Sakuma Y, et al. Evaluation of histo­logical changes in back muscle injuries in rats over time. Asian Spine J 2017;11:88-92.

  25. Li Q, Chen J, Chen Y, Cong X, Chen Z. Chronic sci­atic nerve compression induces fibrosis in dorsal root ganglia. Mol Med Rep 2016;13:2393-400.

  26. Boyan BD, Schwartz Z, Swain LD. In vitro studies on the regulation of endochondral ossification by vita­min D. Crit Rev Oral Biol Med 1992;3:15-30.

  27. Dziewiatkowski DD. Vitamin D and endochondral ossification in the rat as indicated by the use of sul­fur-35 and phosphorus-32. J Exp Med 1954;100:25-32.

  28. Moldovan F, Hassan A, Bagu E, Zaouter C, Patten SA. Could estrogen impact a new pertinent gene for AIS? Scoliosis

  29. Leboeuf D, Letellier K, Alos N, Edery P, Moldovan F. Do estrogens impact adolescent idiopathic scoliosis? Trends Endocrinol Metab 2009;20:147-52.

  30. Kinuta K, Tanaka H, Moriwake T, Aya K, Kato S, Seino Y. Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. Endo­crinology 2000;141:1317-24.

  31. Halloran BP, DeLuca HF. Effect of vitamin D defi­ciency on fertility and reproductive capacity in the female rat. J Nutr 1980;110:1573-80.

  32. Knight JA, Wong J, Blackmore KM, Raboud JM, Vieth R. Vitamin D association with estradiol and progesterone in young women. Cancer Causes Con­trol 2010;21:479-83.

  33. Arai S, Ohtsuka Y, Moriya H, Kitahara H, Minami S. Scoliosis associated with syringomyelia. Spine (Phila Pa 1976) 1993;18:1591-2.

  34. Isu T, Chono Y, Iwasaki Y, et al. Scoliosis associated with syringomyelia presenting in children. Childs Nerv Syst 1992;8:97-100.

  35. Cheng JC, Chau WW, Guo X, Chan YL. Redefining the magnetic resonance imaging reference level for the cerebellar tonsil: a study of 170 adolescents with normal versus idiopathic scoliosis. Spine (Phila Pa 1976) 2003;28:815-8.

  36. Chu WC, Man GC, Lam WW, et al. A detailed morphologic and functional magnetic resonance imaging study of the craniocervical junction in ado­lescent idiopathic scoliosis. Spine (Phila Pa 1976) 2007;32:1667-74.

  37. Sun X, Qiu Y, Zhu Z, et al. Variations of the posi­tion of the cerebellar tonsil in idiopathic scoliotic adolescents with a cobb angle >40 degrees: a mag­netic resonance imaging study. Spine (Phila Pa 1976) 2007;32:1680-6.

  38. Dretakis EK. Brain-stem dysfunction and idiopathic scoliosis. Stud Health Technol Inform 2002;91:422-7.

  39. Geissele AE, Kransdorf MJ, Geyer CA, Jelinek JS, Van Dam BE. Magnetic resonance imaging of the brain stem in adolescent idiopathic scoliosis. Spine (Phila Pa 1976) 1991;16:761-3.

  40. Chu WC, Shi L, Wang D, et al. Variations of semicir­cular canals orientation and left-right asymmetry in adolescent idiopathic scoliosis (AIS) comparing with normal controls: MR morphometry study using ad­vanced image computation techniques. Stud Health Technol Inform 2008;140;333.

  41. Simoneau M, Richer N, Mercier P, Allard P, Teas­dale N. Sensory deprivation and balance control in idiopathic scoliosis adolescent. Exp Brain Res 2006;170:576-82.

  42. Barrack RL, Wyatt MP, Whitecloud TS 3rd, Burke SW, Roberts JM, Brinker MR. Vibratory hyper­sensitivity in idiopathic scoliosis. J Pediatr Orthop 1988;8:389-95.

  43. Wiener-Vacher SR, Mazda K. Asymmetric otolith vestibulo-ocular responses in children with idiopath­ic scoliosis. J Pediatr 1998;132:1028-32.

  44. Pialasse JP, Descarreaux M, Mercier P, Blouin J, Sim­oneau M. The vestibular-evoked postural response of adolescents with idiopathic scoliosis is altered. PLoS One 2015;10:e0143124.

  45. Guo X, Chau WW, Hui-Chan CW, Cheung CS, Tsang WW, Cheng JC. Balance control in adolescents with idiopathic scoliosis and disturbed somatosensory function. Spine (Phila Pa 1976) 2006;31:E437-40.

  46. Lao ML, Chow DH, Guo X, Cheng JC, Holmes AD. Impaired dynamic balance control in adolescents with idiopathic scoliosis and abnormal somatosenso­ry evoked potentials. J Pediatr Orthop 2008;28:846-9.

  47. Beaulieu M, Toulotte C, Gatto L, et al. Postural im­balance in non-treated adolescent idiopathic scolio­sis at different periods of progression. Eur Spine J 2009;18:38-44.

  48. Veldhuizen AG, Wever DJ, Webb PJ. The aetiology of idiopathic scoliosis: biomechanical and neuromuscu­lar factors. Eur Spine J 2000;9:178-84.

  49. Haumont T, Gauchard GC, Lascombes P, Perrin PP. Postural instability in early-stage idiopathic scoliosis in adolescent girls. Spine (Phila Pa 1976) 2011;36:E847-54.

  50. McGrath JJ, Feron FP, Burne TH, Mackay-Sim A, Ey­les DW. Vitamin D3-implications for brain develop­ment. J Steroid Biochem Mol Biol 2004;89-90:557-60.

  51. Hawes JE, Tesic D, Whitehouse AJ, Zosky GR, Smith JT, Wyrwoll CS. Maternal vitamin D deficiency alters fetal brain development in the BALB/c mouse. Behav Brain Res 2015;286:192-200.

  52. Cui X, Gooch H, Petty A, McGrath JJ, Eyles D. Vita­min D and the brain: genomic and non-genomic ac­tions. Mol Cell Endocrinol 2017;453:131-43.

  53. Stumpf WE, Sar M, Reid FA, Tanaka Y, DeLuca HF. Target cells for 1,25-dihydroxyvitamin D3 in intesti­nal tract, stomach, kidney, skin, pituitary, and para­thyroid. Science 1979;206:1188-90.

  54. Stumpf WE, Sar M, Narbaitz R, Reid FA, DeLuca HF, Tanaka Y. Cellular and subcellular localization of 1,25-(OH)2-vitamin D3 in rat kidney: comparison with localization of parathyroid hormone and estra­diol. Proc Natl Acad Sci U S A 1980;77:1149-53.

  55. Stumpf WE, O’Brien LP. 1,25 (OH)2 vitamin D3 sites of action in the brain: an autoradiographic study. Histochemistry 1987;87:393-406.

  56. Eyles D, Brown J, Mackay-Sim A, McGrath J, Feron F. Vitamin D3 and brain development. Neuroscience 2003;118:641-53.

  57. Feron F, Burne TH, Brown J, et al. Developmental vitamin D3 deficiency alters the adult rat brain. Brain Res Bull 2005;65:141-8.

  58. Annweiler C, Montero-Odasso M, Hachinski V, Se­shadri S, Bartha R, Beauchet O. Vitamin D concen­tration and lateral cerebral ventricle volume in older adults. Mol Nutr Food Res 2013;57:267-76.

  59. Annweiler C, Beauchet O, Bartha R, Hachinski V, Montero-Odasso M; WALK Team (Working group Angers-London for Knowledge). Vitamin D and caudal primary motor cortex: a magnetic resonance spectroscopy study. PLoS One 2014;9:e87314.

  60. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1 al­pha-hydroxylase in human brain. J Chem Neuroanat 2005;29:21-30.

  61. Gezen-Ak D, Dursun E, Yilmazer S. Vitamin D inquiry in hippocampal neurons: consequences of vitamin D-VDR pathway disruption on calcium channel and the vitamin D requirement. Neurol Sci 2013;34:1453-8.

  62. Pérez-Fernandez R, Alonso M, Segura C, et al. Vita­min D receptor gene expression in human pituitary gland. Life Sci 1997;60:35-42.

  63. Kuether TA, Piatt JH. Chiari malformation associ­ated with vitamin D-resistant rickets: case report. Neurosurgery 1998;42:1168-71.

  64. Zhang W, Sha S, Xu L, Liu Z, Qiu Y, Zhu Z. The prevalence of intraspinal anomalies in infantile and juvenile patients with “presumed idiopathic” scolio­sis: a MRI-based analysis of 504 patients. BMC Mus­culoskelet Disord 2016;17:189.

  65. Minasyan A, Keisala T, Zou J, et al. Vestibular dys­function in vitamin D receptor mutant mice. J Ste­roid Biochem Mol Biol 2009;114:161-6.

  66. Beauchet O, Annweiler C, Verghese J, Fantino B, Herrmann FR, Allali G. Biology of gait control: vita­min D involvement. Neurology 2011;76:1617-22.

  67. Krause M, Anschutz W, Vettorazzi E, Breer S, Am­ling M, Barvencik F. Vitamin D deficiency intensifies deterioration of risk factors, such as male sex and absence of vision, leading to increased postural body sway. Gait Posture 2014;39:166-71.

  68. Kalueff AV, Lou YR, Laaksi I, Tuohimaa P. Impaired motor performance in mice lacking neurosteroid vi­tamin D receptors. Brain Res Bull 2004;64:25-9.

  69. Anek A, Bunyaratavej N, Jittivilai T. Effects of short-term vitamin D supplementation on musculoskeletal and body balance for prevention of falling in post­menopausal women. J Med Assoc Thai 2015;98 Suppl 8:S26-31.

  70. Cangussu LM, Nahas-Neto J, Orsatti CL, et al. Ef­fect of isolated vitamin D supplementation on the rate of falls and postural balance in postmenopausal women fallers: a randomized, double-blind, placebo-controlled trial. Menopause 2016;23:267-74.

  71. Saito K, Miyakoshi N, Matsunaga T, Hongo M, Ka­sukawa Y, Shimada Y. Eldecalcitol improves muscle strength and dynamic balance in postmenopausal women with osteoporosis: an open-label randomized controlled study. J Bone Miner Metab 2016;34:547-54.

  72. Sanyelbhaa H, Sanyelbhaa A. Vestibular-evoked myo­genic potentials and subjective visual vertical testing in patients with vitamin D deficiency/insufficiency. Eur Arch Otorhinolaryngol 2015;272:3233-9.

  73. Nordwall A, Willner S. A study of skeletal age and height in girls with idiopathic scoliosis. Clin Orthop Relat Res 1975;(110):6-10.

  74. Archer IA, Dickson RA. Stature and idiopathic scoliosis: a prospective study. J Bone Joint Surg Br 1985;67:185-8.

  75. Nicolopoulos KS, Burwell RG, Webb JK. Stature and its components in adolescent idiopathic scoliosis: cephalo-caudal disproportion in the trunk of girls. J Bone Joint Surg Br 1985;67:594-601.

  76. Ylikoski M. Height of girls with adolescent idiopathic scoliosis. Eur Spine J 2003;12:288-91.

  77. Goldberg CJ, Dowling FE, Fogarty EE. Adolescent idiopathic scoliosis: early menarche, normal growth. Spine (Phila Pa 1976) 1993;18:529-35.

  78. Kitagawa I, Kitagawa Y, Kawase Y, Nagaya T, Toku­dome S. Advanced onset of menarche and higher bone mineral density depending on vitamin D receptor gene polymorphism. Eur J Endocrinol 1998;139:522-7.

  79. Ylikoski M, Peltonen J, Poussa M. Biological factors and predictability of bracing in adolescent idiopathic scoliosis. J Pediatr Orthop 1989;9:680-3.

  80. Siu King Cheung C, Tak Keung Lee W, Kit Tse Y, et al. Abnormal peri-pubertal anthropometric measure­ments and growth pattern in adolescent idiopathic scoliosis: a study of 598 patients. Spine (Phila Pa 1976) 2003;28:2152-7.

  81. Warren MP, Brooks-Gunn J, Hamilton LH, Warren LF, Hamilton WG. Scoliosis and fractures in young ballet dancers: relation to delayed menarche and sec­ondary amenorrhea. N Engl J Med 1986;314:1348-53.

  82. Mao SH, Jiang J, Sun X, et al. Timing of menarche in Chinese girls with and without adolescent idiopathic scoliosis: current results and review of the literature. Eur Spine J 2011;20:260-5.

  83. Yim AP, Yeung HY, Hung VW, et al. Abnormal skel­etal growth patterns in adolescent idiopathic scolio­sis: a longitudinal study until skeletal maturity. Spine (Phila Pa 1976) 2012;37:E1148-54.

  84. Janusz P, Kotwicka M, Andrusiewicz M, Czaprowski D, Czubak J, Kotwicki T. Estrogen receptors genes polymorphisms and age at menarche in idiopathic scoliosis. BMC Musculoskelet Disord 2014;15:383.

  85. Treloar SA, Martin NG. Age at menarche as a fitness trait: nonadditive genetic variance detected in a large twin sample. Am J Hum Genet 1990;47:137-48.

  86. Villamor E, Marin C, Mora-Plazas M, Baylin A. Vita­min D deficiency and age at menarche: a prospective study. Am J Clin Nutr 2011;94:1020-5.

  87. Grivas TB, Vasiliadis E, Mouzakis V, Mihas C, Koufo­poulos G. Association between adolescent idiopathic scoliosis prevalence and age at menarche in different geographic latitudes. Scoliosis 2006;1:9.

  88. Dossus L, Kvaskoff M, Bijon A, et al. Latitude and ultraviolet radiation dose in the birthplace in rela­tion to menarcheal age in a large cohort of French women. Int J Epidemiol 2013;42:590-600.

  89. Sohn K. The influence of climate on age at menarche: augmented with the influence of ancestry. Homo 2016;67:328-36.

  90. Hagenau T, Vest R, Gissel TN, et al. Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int 2009;20:133-40.

  91. Yermachenko A, Dvornyk V. Nongenetic deter­minants of age at menarche: a systematic review. Biomed Res Int 2014;2014:371583.

  92. Lundqvist J. Vitamin D as a regulator of steroido­genic enzymes. F1000Research 2014;3:155. https://doi.org/10.12688/f1000research.4714.1.

  93. Krishnan AV, Swami S, Feldman D. Vitamin D and breast cancer: inhibition of estrogen synthesis and signaling. J Steroid Biochem Mol Biol 2010;121:343-8.

  94. Yu WS, Chan KY, Yu FW, et al. Bone structural and mechanical indices in adolescent idiopathic scoliosis evaluated by high-resolution peripheral quantita­tive computed tomography (HR-pQCT). Bone 2014;61:109-15.

  95. Cheng JC, Qin L, Cheung CS, et al. Generalized low areal and volumetric bone mineral density in adolescent idiopathic scoliosis. J Bone Miner Res 2000;15:1587-95.

  96. Cheung TF, Cheuk KY, Yu FW, et al. Prevalence of vitamin D insufficiency among adolescents and its correlation with bone parameters using high-resolution peripheral quantitative computed tomog­raphy. Osteoporos Int 2016;27:2477-88.

  97. Burner WL 3rd, Badger VM, Sherman FC. Osteo­porosis and acquired back deformities. J Pediatr Orthop 1982;2:383-5.

  98. Velis KP, Healey JH, Schneider R. Osteoporosis in unstable adult scoliosis. Clin Orthop Relat Res 1988;(237):132-41.

  99. Cheng JC, Guo X. Osteopenia in adolescent id­iopathic scoliosis: a primary problem or second­ary to the spinal deformity? Spine (Phila Pa 1976) 1997;22:1716-21.

  100. Yip BH, Yu FW, Wang Z, et al. Prognostic value of bone mineral density on curve progression: a lon­gitudinal cohort study of 513 girls with adolescent idiopathic scoliosis. Sci Rep 2016;6:39220.

  101. Wang ZW, Lee WY, Lam TP, et al. Defining the bone morphometry, micro-architecture and volu­metric density profile in osteopenic vs non-os­teopenic adolescent idiopathic scoliosis. Eur Spine J 2017;26:1586-94.

  102. Tam EM, Yu FW, Hung VW, et al. Are volumetric bone mineral density and bone micro-architecture associated with leptin and soluble leptin receptor levels in adolescent idiopathic scoliosis?: a case-control study. PLoS One 2014;9:e87939.

  103. Suh KT, Lee SS, Hwang SH, Kim SJ, Lee JS. Elevated soluble receptor activator of nuclear factor-kappaB ligand and reduced bone mineral density in patients with adolescent idiopathic scoliosis. Eur Spine J 2007;16:1563-9.

  104. Silva RT, Fernandes RJ, Ono AH, Marcon RM, Cristante AF, de Barros Filho TE. Role of differ­ent hormones in the pathogenesis and severity of adolescent idiopathic scoliosis. Acta Ortop Bras 2017;25:15-7.

  105. Lehtonen-Veromaa MK, Mottonen TT, Nuotio IO, Irjala KM, Leino AE, Viikari JS. Vitamin D and at­tainment of peak bone mass among peripubertal Finnish girls: a 3-y prospective study. Am J Clin Nutr 2002;76:1446-53.

  106. Zhu K, Oddy WH, Holt P, et al. Tracking of vitamin D status from childhood to early adulthood and its association with peak bone mass. Am J Clin Nutr 2017;106:276-83.

  107. Cashman KD, Hill TR, Cotter AA, et al. Low vita­min D status adversely affects bone health param­eters in adolescents. Am J Clin Nutr 2008;87:1039-44.

  108. Sayers A, Fraser WD, Lawlor DA, Tobias JH. 25-Hydroxyvitamin-D3 levels are positively related to subsequent cortical bone development in child­hood: findings from a large prospective cohort study. Osteoporos Int 2012;23:2117-28.

  109. Fox KM, Magaziner J, Sherwin R, et al. Reproduc­tive correlates of bone mass in elderly women: study of Osteoporotic Fractures Research Group. J Bone Miner Res 1993;8:901-8.

  110. Tuppurainen M, Kroger H, Saarikoski S, Honkanen R, Alhava E. The effect of gynecological risk fac­tors on lumbar and femoral bone mineral density in peri- and postmenopausal women. Maturitas 1995;21:137-45.

  111. Gerdhem P, Obrant KJ. Bone mineral density in old age: the influence of age at menarche and meno­pause. J Bone Miner Metab 2004;22:372-5.

  112. Apter D, Vihko R. Premenarcheal endocrine chang­es in relation to age at menarche. Clin Endocrinol (Oxf) 1985;22:753-60.

  113. Chang HK, Chang DG, Myong JP, et al. Bone mineral density among Korean females aged 20-50 years: influence of age at menarche (The Korea National Health and Nutrition Examination Survey 2008-2011). Osteoporos Int 2017;28:2129-36.

  114. Ho AY, Kung AW. Determinants of peak bone min­eral density and bone area in young women. J Bone Miner Metab 2005;23:470-5.

  115. Chevalley T, Bonjour JP, Ferrari S, Rizzoli R. Influ­ence of age at menarche on forearm bone micro­structure in healthy young women. J Clin Endocri­nol Metab 2008;93:2594-601.

  116. Kulis A, Zarzycki D, Ja?kiewicz J. Concentration of estradiol in girls with idiophatic scoliosis. Ortop Traumatol Rehabil 2006;8:455-9.

  117. Esposito T, Uccello R, Caliendo R, et al. Estrogen receptor polymorphism, estrogen content and idio­pathic scoliosis in human: a possible genetic link­age. J Steroid Biochem Mol Biol 2009;116:56-60.

  118. Man GC, Wong JH, Wang WW, et al. Abnormal melatonin receptor 1B expression in osteoblasts from girls with adolescent idiopathic scoliosis. J Pi­neal Res 2011;50:395-402.

  119. Chen C, Xu C, Zhou T, et al. Abnormal osteogenic and chondrogenic differentiation of human mes­enchymal stem cells from patients with adolescent idiopathic scoliosis in response to melatonin. Mol Med Rep 2016;14:1201-9.

  120. Clark EM, Taylor HJ, Harding I, et al. Association between components of body composition and scoliosis: a prospective cohort study reporting dif­ferences identifiable before the onset of scoliosis. J Bone Miner Res 2014;29:1729-36.

  121. Burwell RG, Clark EM, Dangerfield PH, Moulton A. Adolescent idiopathic scoliosis (AIS): a multifacto­rial cascade concept for pathogenesis and embry­onic origin. Scoliosis Spinal Disord 2016;11:8.

  122. Weinstein SL, Dolan LA, Cheng JC, Danielsson A, Morcuende JA. Adolescent idiopathic scoliosis. Lancet 2008;371:1527-37.

  123. Raczkowski JW. The concentrations of testosterone and estradiol in girls with adolescent idiopathic sco­liosis. Neuro Endocrinol Lett 2007;28:302-4.

  124. Sanders JO, Browne RH, McConnell SJ, Margraf SA, Cooney TE, Finegold DN. Maturity assessment and curve progression in girls with idiopathic scoliosis. J Bone Joint Surg Am 2007;89:64-73.

  125. Kulis A, Gozdzialska A, Dr?g J, et al. Participa­tion of sex hormones in multifactorial pathogen­esis of adolescent idiopathic scoliosis. Int Orthop 2015;39:1227-36.

  126. Cutler GB Jr. The role of estrogen in bone growth and maturation during childhood and adolescence. J Steroid Biochem Mol Biol 1997;61:141-4.

  127. Letellier K, Azeddine B, Parent S, et al. Estrogen cross-talk with the melatonin signaling pathway in human osteoblasts derived from adolescent idio­pathic scoliosis patients. J Pineal Res 2008;45:383-93.

  128. Del Rio B, Garcia Pedrero JM, Martinez-Campa C, et al. Melatonin, an endogenous-specific inhibitor of estrogen receptor alpha via calmodulin. J Biol Chem 2004;279:38294-302.

  129. Sanchez-Barcelo EJ, Mediavilla MD, Tan DX, Reiter RJ. Scientific basis for the potential use of melatonin in bone diseases: osteoporosis and adolescent idio­pathic scoliosis. J Osteoporos 2010;2010:830231.

  130. Gallagher JC, Riggs BL, DeLuca HF. Effect of estro­gen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. J Clin Endocrinol Metab 1980;51:1359-64.

  131. Gilad LA, Bresler T, Gnainsky J, Smirnoff P, Schwartz B. Regulation of vitamin D receptor ex­pression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells. J Endocrinol 2005;185:577-92.

  132. Davoodi F, Brenner RV, Evans SR, et al. Modula­tion of vitamin D receptor and estrogen receptor by 1,25(OH)2-vitamin D3 in T-47D human breast can­cer cells. J Steroid Biochem Mol Biol 1995;54:147-53.

  133. Xu H, Long JR, Li MX, Deng HW. Interaction ef­fects between estrogen receptor alpha and vitamin D receptor genes on age at menarche in Chinese women. Acta Pharmacol Sin 2005;26:860-4.

  134. Willing M, Sowers M, Aron D, et al. Bone mineral density and its change in white women: estrogen and vitamin D receptor genotypes and their interac­tion. J Bone Miner Res 1998;13:695-705.

  135. Machida M, Murai I, Miyashita Y, Dubousset J, Yamada T, Kimura J. Pathogenesis of idiopathic scoliosis: experimental study in rats. Spine (Phila Pa 1976) 1999;24:1985-9.

  136. Dubousset J, Machida M. Possible role of the pineal gland in the pathogenesis of idiopathic scoliosis: ex­perimental and clinical studies. Bull Acad Natl Med 2001;185:593-602.

  137. Brodner W, Krepler P, Nicolakis M, et al. Melatonin and adolescent idiopathic scoliosis. J Bone Joint Surg Br 2000;82:399-403.

  138. Cheung KM, Wang T, Poon AM, et al. The ef­fect of pinealectomy on scoliosis development in young nonhuman primates. Spine (Phila Pa 1976) 2005;30:2009-13.

  139. Yang S, Zheng C, Jiang J, et al. The value of applying a melatonin antagonist (Luzindole) in improving the success rate of the bipedal rat scoliosis model. BMC Musculoskelet Disord 2017;18:137.

  140. Azeddine B, Letellier K, Wang da S, Moldovan F, Moreau A. Molecular determinants of melatonin signaling dysfunction in adolescent idiopathic sco­liosis. Clin Orthop Relat Res 2007;462:45-52.

  141. Nakade O, Koyama H, Ariji H, Yajima A, Kaku T. Melatonin stimulates proliferation and type I colla­gen synthesis in human bone cells in vitro. J Pineal Res 1999;27:106-10.

  142. Satomura K, Tobiume S, Tokuyama R, et al. Mela­tonin at pharmacological doses enhances human osteoblastic differentiation in vitro and promotes mouse cortical bone formation in vivo. J Pineal Res 2007;42:231-9.

  143. Roth JA, Kim BG, Lin WL, Cho MI. Melatonin pro­motes osteoblast differentiation and bone forma­tion. J Biol Chem 1999;274:22041-7.

  144. Feskanich D, Hankinson SE, Schernhammer ES. Nightshift work and fracture risk: the Nurses’ Health Study. Osteoporos Int 2009;20:537-42.

  145. Reiter RJ, Tan DX, Korkmaz A. The circadian mela­tonin rhythm and its modulation: possible impact on hypertension. J Hypertens Suppl 2009;27:S17-20.

  146. Golan D, Halhal B, Glass-Marmor L, et al. Vitamin D supplementation for patients with multiple scle­rosis treated with interferon-beta: a randomized controlled trial assessing the effect on flu-like symp­toms and immunomodulatory properties. BMC Neurol 2013;13:60.

  147. Brzezinski A. Melatonin in humans. N Engl J Med 1997;336:186-95.

  148. Hajimohammadi M, Shab-Bidar S, Neyestani TR. Vitamin D and serum leptin: a systematic review and meta-analysis of observational studies and randomized controlled trials. Eur J Clin Nutr 2017;71:1144-53.

  149. Upadhyay J, Farr OM, Mantzoros CS. The role of leptin in regulating bone metabolism. Metabolism 2015;64:105-13.

  150. Qiu Y, Sun X, Qiu X, et al. Decreased circulating leptin level and its association with body and bone mass in girls with adolescent idiopathic scoliosis. Spine (Phila Pa 1976) 2007;32:2703-10.

  151. Barrios C, Cortes S, Perez-Encinas C, et al. Anthro­pometry and body composition profile of girls with nonsurgically treated adolescent idiopathic scolio­sis. Spine (Phila Pa 1976) 2011;36:1470-7.

  152. Takeda S. Leptin and beta-blockers in bone metabo­lism. Clin Calcium 2004;14:241-7.

  153. Thomas T, Gori F, Khosla S, Jensen MD, Burguera B, Riggs BL. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 1999;140:1630-8.

  154. Holloway WR, Collier FM, Aitken CJ, et al. Leptin inhibits osteoclast generation. J Bone Miner Res 2002;17:200-9.

  155. Matkovic V, Ilich JZ, Skugor M, et al. Leptin is inversely related to age at menarche in human fe­males. J Clin Endocrinol Metab 1997;82:3239-45.

  156. Gibson WT, Farooqi IS, Moreau M, et al. Congeni­tal leptin deficiency due to homozygosity for the Delta133G mutation: report of another case and evaluation of response to four years of leptin thera­py. J Clin Endocrinol Metab 2004;89:4821-6.

  157. Giudici KV PhD, Fisberg RM, Marchioni DML, Pe­ters BSE, Martini LA. Crosstalk between bone and fat tissue: associations between vitamin D, osteocal­cin, adipokines, and markers of glucose metabolism among adolescents. J Am Coll Nutr 2017;36:273-80.

  158. Menendez C, Lage M, Peino R, et al. Retinoic acid and vitamin D(3) powerfully inhibit in vitro leptin secretion by human adipose tissue. J Endocrinol 2001;170:425-31.

  159. Kim JH, Choi JH. Pathophysiology and clinical characteristics of hypothalamic obesity in children and adolescents. Ann Pediatr Endocrinol Metab 2013;18:161-7.

  160. Maetani M, Maskarinec G, Franke AA, Cooney RV. Association of leptin, 25-hydroxyvitamin D, and parathyroid hormone in women. Nutr Cancer 2009;61:225-31.

  161. Burwell RG, Dangerfield PH, Moulton A, Grivas TB. Adolescent idiopathic scoliosis (AIS), envi­ronment, exposome and epigenetics: a molecular perspective of postnatal normal spinal growth and the etiopathogenesis of AIS with consideration of a network approach and possible implications for medical therapy. Scoliosis 2011;6:26.

  162. Wajchenberg M, Martins DE, Lazar M. What is the best way to determine the cause of adolescent idio­pathic scoliosis? Ann Transl Med 2015;3:48.

  163. Artaza JN, Norris KC. Vitamin D reduces the ex­pression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. J Endocrinol 2009;200:207-21.

  164. Lebel A, Lebel VA. Severe progressive scoliosis in an adult female possibly secondary thoracic surgery in childhood treated with scoliosis specific Schroth physiotherapy: case presentation. Scoliosis Spinal Disord 2016;11(Suppl 2):41.

  165. Brooks WJ, Krupinski EA, Hawes MC. Reversal of childhood idiopathic scoliosis in an adult, without surgery: a case report and literature review. Scoliosis 2009;4:27.

  166. Guillemant J, Le HT, Maria A, Allemandou A, Peres G, Guillemant S. Wintertime vitamin D deficiency in male adolescents: effect on parathyroid function and response to vitamin D3 supplements. Osteopo­ros Int 2001;12:875-9.

  167. Sullivan SS, Rosen CJ, Halteman WA, Chen TC, Holick MF. Adolescent girls in Maine are at risk for vitamin D insufficiency. J Am Diet Assoc 2005;105:971-4.

  168. Rockell JE, Green TJ, Skeaff CM, et al. Season and ethnicity are determinants of serum 25-hydroxyvi­tamin D concentrations in New Zealand children aged 5-14 y. J Nutr 2005;135:2602-8.

  169. Kalkwarf HJ, Khoury JC, Bean J, Elliot JG. Vitamin K, bone turnover, and bone mass in girls. Am J Clin Nutr 2004;80:1075-80.

  170. Van Summeren M, Braam L, Noirt F, Kuis W, Ver­meer C. Pronounced elevation of undercarboxyl­ated osteocalcin in healthy children. Pediatr Res 2007;61:366-70.

  171. Chinda D, Shimoyama T, Iino C, Matsuzaka M, Na­kaji S, Fukuda S. Decrease of estradiol and several lifestyle factors, but not helicobacter pylori infec­tion, are significant risks for osteopenia in Japanese females. Digestion 2017;96:103-9.

  172. Xiong B, Sevastik JA, Hedlund R, Sevastik B. Radio­graphic changes at the coronal plane in early scolio­sis. Spine (Phila Pa 1976) 1994;19:159-64.

  173. Scherrer SA, Begon M, Leardini A, Coillard C, Rivard CH, Allard P. Three-dimensional vertebral wedging in mild and moderate adolescent idiopath­ic scoliosis. PLoS One 2013;8:e71504.

  174. Begon M, Scherrer SA, Coillard C, Rivard CH, Al­lard P. Three-dimensional vertebral wedging and pelvic asymmetries in the early stages of adolescent idiopathic scoliosis. Spine J 2015;15:477-86.

  175. Stokes IA, Aronsson DD. Disc and vertebral wedg­ing in patients with progressive scoliosis. J Spinal Disord 2001;14:317-22.

  176. Modi HN, Suh SW, Song HR, Yang JH, Kim HJ, Modi CH. Differential wedging of vertebral body and intervertebral disc in thoracic and lumbar spine in adolescent idiopathic scoliosis: a cross sectional study in 150 patients. Scoliosis 2008;3:11.

  177. Will RE, Stokes IA, Qiu X, Walker MR, Sanders JO. Cobb angle progression in adolescent scoliosis be­gins at the intervertebral disc. Spine (Phila Pa 1976) 2009;34:2782-6.

  178. Taylor TK, Ghosh P, Bushell GR. The contribution of the intervertebral disk to the scoliotic deformity. Clin Orthop Relat Res 1981;(156):79-90.

  179. Keenan BE, Izatt MT, Askin GN, et al. Sequential magnetic resonance imaging reveals individual level deformities of vertebrae and discs in the growing scoliotic spine. Spine Deform 2017;5:197-207.

  180. Wang S, Qiu Y, Ma W, et al. Comparison of disc and vertebral wedging between patients with adolescent idiopathic scoliosis and Chiari malformation-asso­ciated scoliosis. J Spinal Disord Tech 2012;25:277-84.

  181. Stokes IA. Mechanical modulation of spinal growth and progression of adolescent scoliosis. Stud Health Technol Inform 2008;135:75-83.

  182. Stokes IA. Analysis and simulation of progressive adolescent scoliosis by biomechanical growth mod­ulation. Eur Spine J 2007;16:1621-8.

  183. Pollintine P, Luo J, Offa-Jones B, Dolan P, Adams MA. Bone creep can cause progressive vertebral de­formity. Bone 2009;45:466-72.

  184. Luo J, Pollintine P, Gomm E, Dolan P, Adams MA. Vertebral deformity arising from an accelerated “creep” mechanism. Eur Spine J 2012;21:1684-91.

  185. Wren TA, Ponrartana S, Aggabao PC, Poorghasami­ans E, Gilsanz V. Association between vertebral cross-sectional area and vertebral wedging in chil­dren and adolescents: a cross-sectional analysis. J Bone Miner Res 2017;32:2257-62.

  186. Wang WJ, Sun C, Liu Z, et al. Transcription fac­tor Runx2 in the low bone mineral density of girls with adolescent idiopathic scoliosis. Orthop Surg 2014;6:8-14.

  187. Obarzanek E, Hunsberger SA, Van Horn L, et al. Safety of a fat-reduced diet: the Dietary Intervention Study in Children (DISC). Pediatrics 1997;100:51-9.

  188. Obarzanek E, Hunsberger SA, van Horn L, et al. Safety of a fat-reduced diet: the Dietary Intervention Study in Children (DISC). Pediatrics 1997;100:51-9.



Return to the VITAMIN D Page

Return to the CHIROPRACTIC AND SCOLIOSIS Page

Since 11-10-2018

                       © 1995–2019 ~ The Chiropractic Resource Organization ~ All Rights Reserved